Greenville Health System (GHS) Cancer Institute — Greenville, South Carolina

Greenville Health System (GHS) Cancer Institute is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Greenville Health System (GHS) Cancer Institute has participated in 3 clinical trials.

Therapeutic areas: Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Myelodysplastic Syndrome.

Sponsors: Calithera Biosciences, Inc, Traws Pharma, Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenville Health System (GHS) Cancer Institute?

Greenville Health System (GHS) Cancer Institute has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenville Health System (GHS) Cancer Institute conducted?

Greenville Health System (GHS) Cancer Institute has 3 clinical trials on record. Their work covers Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Myelodysplastic Syndrome.

Is Greenville Health System (GHS) Cancer Institute accredited by Crixeo Health?

Greenville Health System (GHS) Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Greenville Health System (GHS) Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.